Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Renwick

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pediatric Blood & Cancer|December 23, 2025
Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma RiskJi Yun Tark, Alexander Renwick, Yao Yu, et al.
NPJ Precision Oncology|February 6, 2025
Bio-primed machine learning to enhance discovery of relevant biomarkersDavid M Henke, Alexander Renwick, Joseph R Zoeller, et al.
Elife|July 24, 2013
Integrative genomic analysis of the human immune response to influenza vaccinationLuis M Franco, Kristine L Bucasas, Janet M Wells, et al.
American Journal of Medical Genetics. Part A|December 23, 2025
A Population-Based Assessment of Cancer Risk in Children With VACTERLJi Yun Tark, Alexander Renwick, Giorgio Tettamanti, et al.
EMBO Reports|August 8, 2023
Sox7-positive endothelial progenitors establish coronary arteries and govern ventricular compactionIvy Kn Chiang, David Humphrey, Richard J Mills, et al.
Nature Genetics|November 10, 2015
Mutations in the transcriptional repressor REST predispose to Wilms tumorShazia S Mahamdallie, Sandra Hanks, Kristen L Karlin, et al.
Cell Reports|December 3, 2014
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressorKristen L Karlin, Gourish Mondal, Jessica K Hartman, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2<sup>+</sup> Breast CancerXiaowei Xu, Carmine De Angelis, Kathleen A Burke, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pediatric Blood & Cancer|December 23, 2025
Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma RiskJi Yun Tark, Alexander Renwick, Yao Yu, et al.
NPJ Precision Oncology|February 6, 2025
Bio-primed machine learning to enhance discovery of relevant biomarkersDavid M Henke, Alexander Renwick, Joseph R Zoeller, et al.
Elife|July 24, 2013
Integrative genomic analysis of the human immune response to influenza vaccinationLuis M Franco, Kristine L Bucasas, Janet M Wells, et al.
American Journal of Medical Genetics. Part A|December 23, 2025
A Population-Based Assessment of Cancer Risk in Children With VACTERLJi Yun Tark, Alexander Renwick, Giorgio Tettamanti, et al.
EMBO Reports|August 8, 2023
Sox7-positive endothelial progenitors establish coronary arteries and govern ventricular compactionIvy Kn Chiang, David Humphrey, Richard J Mills, et al.
Nature Genetics|November 10, 2015
Mutations in the transcriptional repressor REST predispose to Wilms tumorShazia S Mahamdallie, Sandra Hanks, Kristen L Karlin, et al.
Cell Reports|December 3, 2014
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressorKristen L Karlin, Gourish Mondal, Jessica K Hartman, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2<sup>+</sup> Breast CancerXiaowei Xu, Carmine De Angelis, Kathleen A Burke, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Pageof 1